Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer

Clinical Lung Cancer

Volumn 14, Issue 4, 2013, Pages 370-375

  Sher, David J ^a   Gielda, Benjamin T ^a   Liptay, Michael J ^a   Warren, William H ^a   Batus, Marta ^a   Fidler, Mary Jo ^a   Garg, Shalini ^a   Bonomi, Philip ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemoradiotherapy; NSCLC; Prognostic factors

Indexed keywords

CARBOPLATIN; ETOPOSIDE; PACLITAXEL; PEMETREXED;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL PREDICTION; TREATMENT DURATION; WEIGHT CHANGE; WEIGHT GAIN;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; WEIGHT GAIN;

EID: 84878788435     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.10.009     Document Type: Article

References (10)

1. A. Jemal, F. Bray, M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. M.A. Dinan, L.H. Curtis, W.R. Carpenter Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003 J Clin Oncol 30 2012 2725 2730
3. W.J. Curran Jr, R. Paulus, C.J. Langer Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 2011 1452 1460
4. R.O. Dillman, J. Herndon, S.L. Seagren Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
5. B.T. Gielda, P. Mehta, A. Khan Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival Int J Radiat Oncol Biol Phys 81 2011 985 991
6. B.T. Gielda, J.C. Marsh, T.W. Zusag Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients J Thorac Oncol 6 2011 1079 1086
7. M.S. Pepe, M. Mori Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12 1993 737 751
8. K.S. Albain, R.S. Swann, V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
9. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
10. C. Schaake-Koning, W. van den Bogaert, O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 1992 524 530